{"id":117,"date":"2022-06-20T22:05:28","date_gmt":"2022-06-20T20:05:28","guid":{"rendered":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/"},"modified":"2022-06-20T22:05:28","modified_gmt":"2022-06-20T20:05:28","slug":"la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent","status":"publish","type":"post","link":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/","title":{"rendered":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent"},"content":{"rendered":"<div>\n<div><meta charset=\"utf-8\"><meta http-equiv=\"x-ua-compatible\" content=\"ie=edge\"><meta name=\"viewport\" content=\"width=device-width, initial-scale=1\"><link href=\"https:\/\/eulawlive.com\/app\/images\/favicon.png\" rel=\"icon\"><meta property=\"twitter:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta property=\"og:image\" name=\"og:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta name=\"twitter:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta name=\"og:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><link type=\"text\/css\" media=\"all\" href=\"https:\/\/eulawlive.com\/app\/cache\/autoptimize\/css\/autoptimize_d31913a95189a55bfb8d211dbb8ed16c.css\" rel=\"stylesheet\"><title>La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament de fer de son concurrent \u2013 Droit de l\u2019UE en direct<\/title><meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1\"><link rel=\"canonical\" href=\"https:\/\/eulawlive.com\/commission-investigates-possible-anticompetitive-dissemination-of-misleading-information-by-vifor-pharma-about-its-competitors-iron-medicine\/\"><meta property=\"og:locale\" content=\"en_GB\"><meta property=\"og:type\" content=\"article\"><meta property=\"og:title\" content=\"Commission investigates possible anticompetitive dissemination of misleading information by Vifor Pharma about its competitor\u2019s iron medicine - EU Law Live\"><meta property=\"og:description\" content=\"The European Commission has opened a formal antitrust investigation to assess whether Vifor Pharma (Switzerland) has restricted competition by illegally disparaging its closest competitor in Europe on the market \u2026 \u00a0 Read more\"><meta property=\"og:url\" content=\"https:\/\/eulawlive.com\/commission-investigates-possible-anticompetitive-dissemination-of-misleading-information-by-vifor-pharma-about-its-competitors-iron-medicine\/\"><meta property=\"og:site_name\" content=\"EU Law Live\"><meta property=\"article:tag\" content=\"News\"><meta property=\"article:section\" content=\"Competition &amp; State Aid\"><meta property=\"article:published_time\" content=\"2022-06-20T13:00:02+00:00\"><meta property=\"article:modified_time\" content=\"2022-06-20T11:19:05+00:00\"><meta property=\"og:updated_time\" content=\"2022-06-20T11:19:05+00:00\"><meta property=\"og:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta property=\"og:image:secure_url\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta property=\"og:image:width\" content=\"494\"><meta property=\"og:image:height\" content=\"237\"><link rel=\"dns-prefetch\" href=\"https:\/\/code.jquery.com\"><meta property=\"og:image\" content=\"https:\/\/eulawlive.com\/logo-final.jpg\"><meta property=\"twitter:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta property=\"og:image\" name=\"og:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta name=\"twitter:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"><meta name=\"og:image\" content=\"https:\/\/eulawlive.com\/app\/uploads\/linkedin_new.png\"> <noscript><iframe loading=\"lazy\" src=\"https:\/\/www.googletagmanager.com\/ns.html?id=GTM-MGMJW89\" height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"><\/iframe><\/noscript>   <\/p>\n<div class=\"wrap\" role=\"document\">\n<div class=\"content\"> <main class=\"main\" style=\"background: url('https:\/\/eulawlive.com\/app\/images\/fondo-body-up.png');background-repeat: no-repeat;background-position: top center;background-size: 918px;\"> <\/p>\n<div class=\"container contenidos-editor-posts\">\n<div class=\"row\">\n<div class=\"col-12 col-lg-11 mx-auto\">\n<div class=\"d-none d-lg-block\">\n<div class=\"fz-10 ff-titilliumweb bg-light border user-post-cat text-center ml-4 mt-4 mt-xl-0 ml-xl-0 d-none\">\n<div class=\"position-relative h-100\">\n<div class=\"position-absolute center-all w-100\">\n<div class=\"pt-1\"> <img decoding=\"async\" class=\"user-image-post-cat mb-2 img-fluid\" src=\"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png\"> <img decoding=\"async\" class=\"user-image-post-cat mb-2 img-fluid\" src=\"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/European-Environment-Agency-warns-of-dangerous-effects-of-land-take.png\"> <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"row d-lg-none\">\n<div class=\"col-lg-11\">\n<div class=\"fz-10 ff-titilliumweb user-post-cat text-center mt-4 mt-xl-0 d-none\">\n<div class=\"position-relative h-100\">\n<div class=\"position-absolute center-all w-100\">\n<div class=\"pt-1\"> <img decoding=\"async\" class=\"user-image-post-cat mb-2 img-fluid\" src=\"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png\"><img decoding=\"async\" class=\"user-image-post-cat mb-2 img-fluid\" src=\"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/European-Environment-Agency-warns-of-dangerous-effects-of-land-take.png\"> <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"row\">\n<div class=\"col-12 col-lg-10 mx-auto border-md-left mb-5\">\n<div class=\"row\">\n<p> <span class=\"text-gray ff-titilliumweb text-uppercase pr-2\">    20 juin 2022 <\/span> <\/p>\n<p> <span class=\"text-primary ff-titilliumweb text-uppercase\">    Concurrence et Aides d\u2019\u00c9tat <i class=\"fa fa-circle text-primary fz-4 pr-2 pl-1\" aria-hidden=\"true\" style=\"vertical-align: 3px;\"><\/i>Consommateur, Sant\u00e9 et Environnement <\/span> <\/p>\n<\/div>\n<div class=\"row\">\n<div class=\"col-12 col-md-11 ml-md-auto\">\n<div class=\"ff-titilliumweb text-justify position-relative no-content\">\n<div class=\"no-pointer\">\n<p>La Commission europ\u00e9enne a ouvert une enqu\u00eate antitrust formelle pour d\u00e9terminer si Vifor Pharma (Suisse) a restreint la concurrence en d\u00e9nigrant ill\u00e9galement son concurrent le plus proche en Europe sur le march\u00e9 du traitement intraveineux au fer \u2013 Pharmacosmos (Danemark).<\/p>\n<p>La Commission a des indications selon lesquelles, pendant des ann\u00e9es, Vifor Pharma a peut-\u00eatre d\u00e9nigr\u00e9 le traitement de la carence en fer de Pharmacosmos, le Monofer, en diffusant des informations trompeuses concernant sa s\u00e9curit\u00e9. Une telle campagne de communication trompeuse pourrait avoir ind\u00fbment entrav\u00e9 l\u2019adoption de Monofer dans l\u2019EEE. La conduite de Vifor Pharma semble viser \u00e0 entraver la concurrence contre son m\u00e9dicament \u00e0 succ\u00e8s pour le traitement du fer par voie intraveineuse \u00e0 haute dose, Ferinject. <\/p>\n<p>Si la conc<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><\/main> <\/div>\n<\/div>\n<div id=\"cookies-hidden\" class=\"position-fixed bg-white py-1 px-3 overflow-x-hidden pointer\" style=\"right: 0; bottom: 0;border: 1px solid var(--primary);\" data-toggle=\"modal\" data-target=\"#configCookies\"> <img decoding=\"async\" class=\"d-inline-block\" src=\"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/La-Commission-envoie-une-communication-des-griefs-a-Apple-sur-1.png\" style=\"max-width: 18px;\"> <span class=\"text-primary fz-18 pl-2\">Cookies<\/span> <\/div>\n<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament de fer de son&#8230;<\/p>\n","protected":false},"author":3,"featured_media":119,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-117","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-droit-de-lenvironnement","wpcat-2-id"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent - TRIBUNAL-NATURE<\/title>\n<meta name=\"description\" content=\"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent article de TRIBUNAL-NATURE\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent - TRIBUNAL-NATURE\" \/>\n<meta property=\"og:description\" content=\"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent article de TRIBUNAL-NATURE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/\" \/>\n<meta property=\"og:site_name\" content=\"TRIBUNAL-NATURE\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-20T20:05:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/vifor-pharma-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Isabelle LOUBEAU\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Isabelle LOUBEAU\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/\"},\"author\":{\"name\":\"Isabelle LOUBEAU\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#\\\/schema\\\/person\\\/55761caf7544da6b05b60523f2a0855f\"},\"headline\":\"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent\",\"datePublished\":\"2022-06-20T20:05:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/\"},\"wordCount\":196,\"publisher\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png\",\"articleSection\":[\"Droit De L'Environnement:\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/\",\"url\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/\",\"name\":\"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent - TRIBUNAL-NATURE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png\",\"datePublished\":\"2022-06-20T20:05:28+00:00\",\"description\":\"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent article de TRIBUNAL-NATURE\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png\",\"contentUrl\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png\",\"width\":80,\"height\":80,\"caption\":\"New antitrust rules on vertical agreements adopted by Commission\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/\",\"name\":\"TRIBUNAL-NATURE\",\"description\":\"Droit De L&#039;Environnement.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#organization\",\"name\":\"tribunal-nature\",\"url\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-2.png\",\"contentUrl\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-2.png\",\"width\":180,\"height\":180,\"caption\":\"tribunal-nature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/#\\\/schema\\\/person\\\/55761caf7544da6b05b60523f2a0855f\",\"name\":\"Isabelle LOUBEAU\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6912620aca78633bf5d50400888815d3b38a1118e82b94050843f411f3f5972?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6912620aca78633bf5d50400888815d3b38a1118e82b94050843f411f3f5972?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6912620aca78633bf5d50400888815d3b38a1118e82b94050843f411f3f5972?s=96&d=mm&r=g\",\"caption\":\"Isabelle LOUBEAU\"},\"url\":\"https:\\\/\\\/www.tribunal-nature.org\\\/blog\\\/author\\\/ureisabelle\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent - TRIBUNAL-NATURE","description":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent article de TRIBUNAL-NATURE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/","og_locale":"fr_FR","og_type":"article","og_title":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent - TRIBUNAL-NATURE","og_description":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent article de TRIBUNAL-NATURE","og_url":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/","og_site_name":"TRIBUNAL-NATURE","article_published_time":"2022-06-20T20:05:28+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/vifor-pharma-scaled.jpg","type":"image\/jpeg"}],"author":"Isabelle LOUBEAU","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Isabelle LOUBEAU","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/#article","isPartOf":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/"},"author":{"name":"Isabelle LOUBEAU","@id":"https:\/\/www.tribunal-nature.org\/blog\/#\/schema\/person\/55761caf7544da6b05b60523f2a0855f"},"headline":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent","datePublished":"2022-06-20T20:05:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/"},"wordCount":196,"publisher":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/#organization"},"image":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/#primaryimage"},"thumbnailUrl":"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png","articleSection":["Droit De L'Environnement:"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/","url":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/","name":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent - TRIBUNAL-NATURE","isPartOf":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/#primaryimage"},"image":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/#primaryimage"},"thumbnailUrl":"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png","datePublished":"2022-06-20T20:05:28+00:00","description":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent article de TRIBUNAL-NATURE","breadcrumb":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/#primaryimage","url":"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png","contentUrl":"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/06\/New-antitrust-rules-on-vertical-agreements-adopted-by-Commission.png","width":80,"height":80,"caption":"New antitrust rules on vertical agreements adopted by Commission"},{"@type":"BreadcrumbList","@id":"https:\/\/www.tribunal-nature.org\/blog\/la-commission-enquete-sur-une-eventuelle-diffusion-anticoncurrentielle-dinformations-trompeuses-par-vifor-pharma-sur-le-medicament-a-base-de-fer-de-son-concurrent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.tribunal-nature.org\/blog\/"},{"@type":"ListItem","position":2,"name":"La Commission enqu\u00eate sur une \u00e9ventuelle diffusion anticoncurrentielle d\u2019informations trompeuses par Vifor Pharma sur le m\u00e9dicament \u00e0 base de fer de son concurrent"}]},{"@type":"WebSite","@id":"https:\/\/www.tribunal-nature.org\/blog\/#website","url":"https:\/\/www.tribunal-nature.org\/blog\/","name":"TRIBUNAL-NATURE","description":"Droit De L&#039;Environnement.","publisher":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.tribunal-nature.org\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.tribunal-nature.org\/blog\/#organization","name":"tribunal-nature","url":"https:\/\/www.tribunal-nature.org\/blog\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.tribunal-nature.org\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/05\/logo-2.png","contentUrl":"https:\/\/www.tribunal-nature.org\/blog\/wp-content\/uploads\/2022\/05\/logo-2.png","width":180,"height":180,"caption":"tribunal-nature"},"image":{"@id":"https:\/\/www.tribunal-nature.org\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.tribunal-nature.org\/blog\/#\/schema\/person\/55761caf7544da6b05b60523f2a0855f","name":"Isabelle LOUBEAU","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/b6912620aca78633bf5d50400888815d3b38a1118e82b94050843f411f3f5972?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b6912620aca78633bf5d50400888815d3b38a1118e82b94050843f411f3f5972?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b6912620aca78633bf5d50400888815d3b38a1118e82b94050843f411f3f5972?s=96&d=mm&r=g","caption":"Isabelle LOUBEAU"},"url":"https:\/\/www.tribunal-nature.org\/blog\/author\/ureisabelle\/"}]}},"_links":{"self":[{"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/posts\/117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/comments?post=117"}],"version-history":[{"count":0,"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/posts\/117\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/media\/119"}],"wp:attachment":[{"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/media?parent=117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/categories?post=117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tribunal-nature.org\/blog\/wp-json\/wp\/v2\/tags?post=117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}